Celltrion Holdings IPO

Seoul Guarantee Insurance Co. (SGI) will raise 181.5 billion won ($124.2 million) through an initial public offering later this month in its second ...

LG Group Chairman Koo Kwang-mo visited LG Electronics Inc.'s factory and research center in India in late February as it plans to list its Indian ar...

CHA Biotech Co., South Korea’s leading stem cell therapeutics developer, plans to resume an initial public offering of CHA Healthcare Co., a m...

LG Electronics Inc. posted its largest-ever sales in India in 2024, providing a boost to the planned initial public offering of its Indian unit this...

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Meritz Financial Group Inc., once a medium-sized financial service firm in South Korea, has become the second-most valuable publicly traded financia...

Global private equity firm KKR & Co. Inc. has succeeded in cashing out of its stake in HD Hyundai Marine Solution Co. for 295 billion won ($206 ...

Meritz Financial Group Inc. has reported its best-ever net profit for last year thanks to handsome gains from investments by its insurance and secur...

Companies in South Korea are expected to refrain from seeking initial public offerings for a while after the country’s much-anticipated new bl...

KB Financial Group Inc., South Korea’s largest financial holding group, will spend nearly 1.8 trillion won ($1.2 billion) to boost shareholder...

South Korean companies are relaunching attempts to go public with lower valuations and fewer shares amid continued sour investor sentiment.CK Soluti...

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

South Korea’s top four financial holding firms are estimated to have posted their highest-ever profits in 2024, driven by hefty interest incom...

South Korea’s business-to-business fintech service provider Dozn is planning an initial public offering on the Kosdaq in February for an estim...

Doosan Skoda Power, the Czech-based power plant equipment-making unit of South Korea’s Doosan Enerbility Co., plans to list its shares on the ...

Seoul Guarantee Insurance Co. (SGI) has slashed its target valuation by about 40% in a renewed attempt to go public on the South Korean stock exchan...

Sono Hospitality Group, South Korea’s top resort operator, has vowed to more actively horn in on the business of T'way Air Co., portending a p...

Korea Investment Holdings Co. said on Thursday it was upgraded by three notches from B to A in the MSCI ESG rating this year.The MSCI ESG rating is ...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

LG CNS Co., an information technology service company, is set to price its initial public offering at the top of its proposed price range to raise 1...

K Bank, a South Korean online lender, said on Wednesday it has again canceled its initial public offering plan amid the languid stock market an...

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

The South Korean fintech industry, which bloomed a decade ago, is poised to take the next step for the coming 10 years after prominent players began...

South Korea’s steel-to-battery materials conglomerate POSCO Group on Monday unveiled a spate of corporate value-up measures, including a highe...

Kurly Inc., South Korea's dawn delivery service market pioneer, has invited a third-party online retailer to sell luxury goods on its platform to bo...

K Bank, a South Korean online lender, is making a fresh attempt to list on the Korean stock market in February 2025 as bitcoin’s record-breaki...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

LG Electronics Inc. will retire 761,000 shares in 2025, or around 0.5% of its outstanding shares, to increase shareholder returns, the South Korean ...

Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...